Spg Therapeutics Inc is categorized under Research and Development Laboratories in Northridge, CA and active since 2009.
Spg Therapeutics Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Zory Shaposhnik at the company’s single location by writing to 9937 Shirley Avenue, Northridge, California CA 91324 or by phoning (818) 709-2709. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Spg Therapeutics Inc |
| Contact Person: | Zory Shaposhnik |
| Address: | 9937 Shirley Avenue, Northridge, California 91324 |
| Phone Number: | (818) 709-2709 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Spg Therapeutics Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Zory Shaposhnik for inquiries that concern Spg Therapeutics Inc by calling the company number (818) 709-2709, as your correspondence is most welcome. Additionally, the physical location of the single location of Spg Therapeutics Inc can be found at the coordinates 34.251365,-118.559218 as well as the street address 9937 Shirley Avenue in Northridge, California 91324.
For its online presence, you may visit Spg Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.